Posted by John Deo
Alnylam Pharmaceuticals (NASDAQ:ALNY) reported adjusted earnings of 6 cents per share, surpassing expectation
Source: Two Blokes Trading
Posted by John Deo
Sapiens International Corporation N.V. (NASDAQ:SPNS) matched its estimated EPS of $0.37 for Q4 2024, marking
Source: Two Blokes Trading
Posted by John Deo
Earnings Per Share (EPS): MGY reported an EPS of $0.449, slightly below the estimated $0.46, but outperformed
Source: Two Blokes Trading
Posted by John Deo
Mullen Automotive Inc. (NASDAQ:MULN) plans a reverse stock split at a ratio of 60 for 1 to meet Nasdaq's mini
Source: Two Blokes Trading
Posted by John Deo
Newmont Corporation, trading as NYSE:NEM, is a leading gold mining company with operations worldwide. It is kn
Source: Two Blokes Trading
Posted by John Deo
STAAR Surgical Company (NASDAQ:STAA) is a prominent player in the medical device industry, specializing in imp
Source: Two Blokes Trading
Posted by John Deo
STAAR Surgical Company (NASDAQ:STAA) is a prominent player in the medical device industry, specializing in imp
Source: Two Blokes Trading
Posted by John Deo
RBC Capital upgrades Carvana (NYSE:CVNA) to "Outperform" amid a bullish trend in used car sales. Carvana's st
Source: Two Blokes Trading
Posted by John Deo
CRISPR Therapeutics AG (NASDAQ:CRSP) reported an EPS of -$0.44, outperforming the estimated EPS of -$1.15. Th
Source: Two Blokes Trading
Posted by John Deo
Aptose Biosciences Inc. (NASDAQ:APTO), a clinical-stage precision oncology company, has announced a reverse st
Source: Two Blokes Trading
Posted by John Deo
Anticipated EPS of $1.08 for the quarter ending December 2024, marking a 22.9% decline year-over-year. Projec
Source: Two Blokes Trading
Posted by John Deo
Analysts estimate an earnings per share (EPS) of $35.82 and project revenues to be around $5.18 billion for t
Source: Two Blokes Trading